NJC
Paper
N-(2,2-Dimethoxyethyl)-5,6-dimethylbenzimidazole, 1b59
NCH2CH2O], 4.04 [t, 2H, J = 6 Hz, NCH2CH2N], 5.37 and 5.53 [d,
4H, J = 5.6 Hz, (CH3)2CHC6H4CH3-p], 7.16 and 7.73 [s, 2H,
NC6H2N], 8.44 [s, 1H, NCHN]. 13C NMR (100 MHz, CDCl3): d =
18.5 [(CH3)2CHC6H4CH3-p], 20.5 and 20.7 [C6H2-5,6-(CH3)2],
22.4 [(CH3)2CHC6H4CH3-p], 30.7 [(CH3)2CHC6H4CH3-p], 42.3
[NCH2CH2], 53.4 [NCH2CH2O], 57.3 [NCH2CH2N], 66.9
[NCH2CH2O], 81.3, 82.3, 97.3 and 102.6 [(CH3)2CHC6H4CH3-p],
110.6, 120.3, 132.3, 132.5, 133.4 and 141.0 [NC6H2N], 144.2
[NCHN]. Elemental analysis: calcd for C25H35N3ORuCl2ÁH2O: C
51.46, H 6.39, N 7.20; found C 52.11, H 6.32, N 7.41%.
1
Yield: 85%, m.p.: 88–89 1C; FT-IR n(CN): 1488 cmÀ1; H NMR
(400 MHz, CDCl3): d = 3.38 [s, 6H, NCH2CH(OCH3)2], 4.26 [d, J =
5.2 Hz, 2H, NCH2CH(OCH3)2], 4.57 [t, J = 5.2 Hz, 1H,
NCH2CH(OCH3)2], 7.44 and 7.81 [d, 2H, J = 8 Hz, NC6H4N],
7.19–7.27 [m, 2H, NC6H4N], 7.88 [s, 1H, NCHN]. 13C NMR
(100 MHz, CDCl3):
d
=
47.3 [NCH2CH(OCH3)2], 55.2
[NCH2CH(OCH3)2], 102.7 [NCH2CH(OCH3)2], 109.5, 120.4,
122.1, 123.0 and 134.0 [NC6H4N], 143.0 [NCHN].
N-(2,2-Dimethoxyethyl)-5,6-dimethylbenzimidazole, 1c
Dichloro-[1-(2,2-dimethoxyethyl)benzimidazole](p-cymene)
ruthenium(II), 2b
Yield: 87%, m.p.: 235–236 1C; FT-IR n(CN): 1512 cmÀ1; 1H NMR
Yield: 75%, m.p.: 103–104 1C; FT-IR n(CN): 103–104 cmÀ1
;
1H NMR (400 MHz, CDCl3): d = 2.38 and 2.40 [s, 6H, C6H2-
5,6-(CH3)2], 3.37 [s, 6H, NCH2CH(OCH3)2], 4.20 [d, J = 5.6 Hz,
2H, NCH2CH(OCH3)2], 4.56 [t, J = 5.6 Hz, 1H, NCH2CH(OCH3)2],
7.19 and 7.56 [s, 2H, NC6H2N], 7.84 [s, 1H, NCHN]. 13C NMR (100
(400 MHz, CDCl3):
d
=
1.27 [d, 6H,
J
=
7.2 Hz,
(CH3)2CHC6H4CH3-p], 2.11 [s, 3H, (CH3)2CHC6H4CH3-p], 2.87
[hept, 1H, J = 6.8 Hz, (CH3)2CHC6H4CH3-p], 3.37 [s, 6H,
NCH2CH(OCH3)2], 4.01 [d, J = 4.4 Hz, 2H, NCH2CH(OCH3)2],
4.48 [t, J = 4.4 Hz, 1H, NCH2CH(OCH3)2], 5.37 and 5.53
[d, 4H, J = 6 Hz, (CH3)2CHC6H4CH3-p], 7.34 and 8.01 [m, 4H,
NC6H4N], 8.32 [s, 1H, NCHN]. 13C NMR (100 MHz, CDCl3):
d = 18.4 [(CH3)2CHC6H4CH3-p], 22.3 [(CH3)2CHC6H4CH3-p],
30.6 [(CH3)2CHC6H4CH3-p], 47.3 [NCH2CH(OCH3)2], 55.2
[NCH2CH(OCH3)2], 102.5 [NCH2CH(OCH3)2], 81.1, 82.9,
97.7 and 102.1 [(CH3)2CHC6H4CH3-p], 111.2, 120.3, 123.3,
124.2, 134.0 and 142.1 [NC6H4N], 145.8 [NCHN]. Elemental
analysis: calcd for C21H28N2O2RuCl2ÁH2O: C 47.55, H 5.70, N
5.28; found C 47.84, H 5.31, N 5.51%.
MHz, CDCl3):
d = 20.2 and 20.6 [C6H2-5,6-(CH3)2], 47.3
[NCH2CH(OCH3)2], 55.2 [NCH2CH(OCH3)2], 102.7 [NCH2CH
(OCH3)2], 109.7, 120.4, 131.1, 132.2, 132.5 and 142.1 [NC6H4N],
143.0 [NCHN].
N-(Diphenylmethyl)benzimidazole, 1d60
Yield: 73%, m.p.: 155–156 1C; FT-IR n(CN): 1448 cmÀ1; 1H NMR
(400 MHz, CDCl3): d = 6.75 [s, 1H, CH(C6H5)2], 7.14–7.36 [m,
13H, NC6H4N and CH(C6H5)2], 7.83[d, J = 8 Hz, Ar], 7.60 [s, 1H,
NCHN]. 13C NMR (100 MHz, CDCl3): d = 63.6 [CH(C6H5)2],
110.6, 120.4, 122.4, 123.0, 128.2, 128.5, 129.0, 134.1, 138.1
and 144.1 [NC6H4N and CH(C6H5)2], 142.3 [NCHN].
Dichloro-[1-(2,2-dimethoxyethyl)-5,6-dimethylbenzimidazole]
(p-cymene)ruthenium(II), 2c
N-(Diphenylmethyl)-5,6-dimethylbenzimidazole, 1e
Yield: 90%, m.p.: 248–249 1C; FT-IR n(CN): 1449 cmÀ1; 1H NMR
(400 MHz, CDCl3): d = 2.28 and 2.35 [s, 6H, C6H2-5,6-(CH3)2],
6.70 [s, 1H, CH(C6H5)2], 6.92 and 7.50 [s, 2H, NC6H2N], 7.14 and
7.35 [s, 10H, CH(C6H5)2], 7.58 [s, 1H, NCHN]. 13C NMR
(100 MHz, CDCl3): d = 20.3 and 20.6 [C6H2-5,6-(CH3)2], 63.4
[CH(C6H5)2], 110.7, 120.4, 128.2, 124.4, 129.0, 131.3, 132.1,
132.7, 138.4 and 141.9 [NC6H2N and CH(C6H5)2], 142.7 [NCHN].
Yield: 95%, m.p.: 237–238 1C; FT-IR n(CN): 1513 cmÀ1; 1H NMR
(400 MHz, CDCl3): d = 1.27 [d, 6H, J = 6.8 Hz, (CH3)2CHC6
H4CH3-p], 2.14 [s, 3H, (CH3)2CHC6H4CH3-p], 2.37 and 2.40 [s,
6H, C6H2-5,6-(CH3)2], 2.88 [hept, 1H, J = 6.8 Hz, (CH3)2CHC6
H4CH3-p], 3.38 [s, 6H, NCH2CH(OCH3)2], 4.09 [d, J = 4.4 Hz, 2H,
NCH2CH(OCH3)2], 4.55 [t, J = 4.4 Hz, 1H, NCH2CH(OCH3)2],
5.37 and 5.52 [d, 4H, J = 6 Hz, (CH3)2CHC6H4CH3-p], 7.16 and
7.74 [s, 2H, NC6H2N], 8.32 [s, 1H, NCHN]. 13C NMR (100 MHz,
CDCl3): d = 18.4 [(CH3)2CHC6H4CH3-p], 20.5 and 20.7 [C6H2-5,6-
(CH3)2], 22.3 [(CH3)2CHC6H4CH3-p], 30.6 [(CH3)2CHC6H4CH3-
p], 47.3 [NCH2CH(OCH3)2], 55.0 [NCH2CH(OCH3)2], 102.5
[NCH2CH(OCH3)2], 81.2, 82.9, 97.6 and 102.1 [(CH3)2CHC6
H4CH3-p], 110.7, 120.3, 132.5, 132.6, 133.6 and 140.9 [NC6H4N],
144.5 [NCHN]. Elemental analysis: calcd for C23H32N2O2RuCl2:
C 51.11, H 5.97, N 5.18; found C 51.31, H 5.74, N 5.481%.
General procedure for the preparation of the N-coordinated
benzimidazole ruthenium(II) complexes
A solution of N-alkylbenzimidazole (1.0 mmol) and [RuCl2
(p-cymene)]2 (0.5 mmol) in 10 mL toluene was heated under
reflux for 5 h. Upon cooling to room temperature, an orange
solid of 2a–e was obtained. The solid (2a–e) was filtered and
washed with diethyl ether (3 Â 10 mL) and dried under vacuum.
The crude product was crystallized in CH2Cl2/Et2O.
Dichloro-[1-(diphenylmethyl)benzimidazole](p-cymene)
Dichloro-[N-2-(morpholinyl)ethyl-5,6-dimethylbenzimidazole]
(p-cymene)ruthenium(II), 2a
Yield: 74%, m.p.: 246–247 1C; FT-IR n(CN): 1513 cmÀ1; 1H NMR (400 MHz, CDCl3): d = 1.12 [d, 6H, J = 6.8 Hz, (CH3)2CHC6
ruthenium(II), 2d
Yield: 80%, m.p.: 227–228 1C; FT-IR n(CN): 1501 cmÀ1; 1H NMR
(400 MHz, CDCl3):
d
=
1.28 [d, 6H,
J
=
6.8 Hz, H4CH3-p], 2.14 [s, 3H, (CH3)2CHC6H4CH3-p], 2.70 [hept, 1H, J =
(CH3)2CHC6H4CH3-p], 2.13 [s, 3H, (CH3)2CHC6H4CH3-p], 2.38 6.8 Hz, (CH3)2CHC6H4CH3-p], 5.31 and 5.41 [d, 4H, J = 6 Hz,
and 2.41 [s, 6H, C6H2-5,6-(CH3)2], 2.45 [t, 4H, J = 4.8 Hz, (CH3)2CHC6H4CH3-p], 6.77 [s, 1H, CH(C6H5)2], 7.09–7.38 [m,
NCH2CH2O], 2.69 [t, 2H, J = 6 Hz, NCH2CH2N], 2.92 [hept, 13H, NC6H4N and CH(C6H5)2], 8.13 [d, J = 8 Hz, Ar], 8.21 [s, 1H,
1H, J = 6.8 Hz, (CH3)2CHC6H4CH3-p], 3.68 [t, 4H, J = 4.8 Hz, NCHN]. 13C NMR (100 MHz, CDCl3): d = 18.5 [(CH3)2CHC6H4CH3-p],
This journal is © The Royal Society of Chemistry and the Centre National de la Recherche Scientifique 2021
New J. Chem., 2021, 45, 11075–11085 | 11077